Peptide Graded

Davunetide

Is Davunetide legal in the US?

No. It is not approved and is sold as a research chemical.

BSome human evidenceIn clinical trialsas of 2026-10-27

Davunetide is not approved by the FDA for any use. It is an investigational peptide whose phase 2/3 trial in progressive supranuclear palsy failed in 2012; no new trial of it has been registered since, and vials sold online are research chemicals.

No. It reached a phase 2/3 trial in progressive supranuclear palsy, which failed in 2012. No new trial has been registered since, and no approval application is pending. 2

Read the full Davunetide page

More on Davunetide

Citations

  1. Gozes 2011, Curr Pharm Des: davunetide (NAP) and microtubules, review doi.org
  2. Boxer 2014, Lancet Neurol: davunetide in patients with progressive supranuclear palsy, randomised double-blind placebo-controlled trial doi.org
  3. Shapira 2026, Mol Psychiatry: sex-specific reanalysis of the davunetide PSP trial pubmed.ncbi.nlm.nih.gov

Reference information only, not medical advice. Drawn from the Davunetide article, fact-checked against the cited sources. No dosing anywhere on this site.